| Primary information |
|---|
| sequence ID | Seq_1155 |
| Peptide sequence | DAYALNHTL |
| CancerPDF_ID | CancerPDF_ID11370, CancerPDF_ID13552, |
| PMID | 26992070,20974924 |
| Protein Name | POU domain class 2-associating factor 1,POU domain class 2-associating factor 1 |
| UniprotKB Entry Name | OBF1_HUMAN,OBF1_HUMAN |
| Fluid | Serum,Plasma |
| M/Z | 1016.4927,1017.501 |
| Charge | NA,2 |
| Mass (in Da) | 1017.503954,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | FDR 1 %,NA |
| CancerPDF_ID | CancerPDF_ID11370, CancerPDF_ID13552, |
| p-Value | NA,NA |
| Software | SEQUEST and Maxquant,MASCOT and SEQUEST |
| Length | 9,NA |
| Cancer Type | Melanoma,"Multiple myeloma patients, Acute myeloid leukemia" |
| Database | SwissProt Database,Uniprot database |
| Modification | NA,NA |
| Number of Patients | 8 cancer samples and 4 healthy samples,NA |
| Regulation | "Present in 2 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples.",NA |
| Validation | na,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | 7683
|